UK Markets closed
  • NIKKEI 225

    27,581.66
    -388.56 (-1.39%)
     
  • HANG SENG

    25,473.88
    +387.45 (+1.54%)
     
  • CRUDE OIL

    72.37
    +0.72 (+1.00%)
     
  • GOLD FUTURES

    1,806.00
    +6.20 (+0.34%)
     
  • DOW

    34,930.93
    -127.59 (-0.36%)
     
  • BTC-GBP

    28,701.32
    +1,013.12 (+3.66%)
     
  • CMC Crypto 200

    938.33
    +8.40 (+0.90%)
     
  • Nasdaq

    14,762.58
    +102.01 (+0.70%)
     
  • ^FTAS

    4,024.08
    +13.79 (+0.34%)
     

Notice of Results

·1-min read

Arix Bioscience PLC (ARIX)
21-Jul-2021 / 07:00 GMT/BST
Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.

Arix Bioscience plc

 

Notice of Results

 

LONDON, 21 July 2021: Arix Bioscience plc ("Arix", LSE: ARIX), a global venture capital company focused on investing in and building breakthrough biotech companies, will announce its interim results for the six months ended 30 June 2021, on Thursday 12 August 2021.

 

[ENDS]

 

Enquiries

For more information on Arix, please contact:

 

Arix Bioscience plc

Charlotte Parry, Head of Investor Relations

+44 (0)20 7290 1072

charlotte@arixbioscience.com

 

Optimum Strategic Communications

Mary Clark, Manel Mateus

+44 (0)20 3922 1906

optimum.arix@optimumcomms.com

 

About Arix Bioscience plc

Arix Bioscience plc is a global venture capital company focused on investing in and building breakthrough biotech companies around cutting-edge advances in life sciences.

 

We collaborate with exceptional entrepreneurs and provide the capital, expertise and global networks to help accelerate their ideas into important new treatments for patients. As a listed company, we are able to bring this exciting growth phase of our industry to a broader range of investors. www.arixbioscience.com

 

 


ISIN:

GB00BD045071

Category Code:

NOR

TIDM:

ARIX

LEI Code:

213800OVT3AHQCXNIX43

OAM Categories:

3.1. Additional regulated information required to be disclosed under the laws of a Member State

Sequence No.:

118082

EQS News ID:

1220491


 

End of Announcement

EQS News Service

show this
show this
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting